Skip to main content

Nixon Peabody LLP

  • People
  • Capabilities
  • Insights
  • About
Trending Topics
    • People
    • Capabilities
    • Insights
    • About
    • Locations
    • Events
    • Careers
    • Alumni
    Practices

    View All

    • Affordable Housing
    • Community Development Finance
    • Corporate & Finance
    • Cybersecurity & Privacy
    • Entertainment & Media
    • Environmental
    • Franchising & Distribution
    • Government Investigations & White Collar Defense
    • Healthcare
    • Intellectual Property
    • International Services
    • Labor, Employment, and Benefits
    • Litigation
    • Private Wealth & Advisory
    • Project Finance
    • Public Finance
    • Real Estate
    • Regulatory & Government Relations
    Industries

    View All

    • Aviation
    • Cannabis
    • Consumer
    • Energy
    • Financial Services
    • Healthcare
    • Higher Education
    • Infrastructure
    • Manufacturing
    • Nonprofit Organizations
    • Real Estate
    • Sports & Stadiums
    • Technology
    Value-Added Services

    View All

    • Alternative Fee Arrangements

      Developing innovative pricing structures and alternative fee agreement models that deliver additional value for our clients.

    • Continuing Education

      Advancing professional knowledge and offering credits for attorneys, staff and other professionals.

    • Crisis Advisory

      Helping clients respond correctly when a crisis occurs.

    • DEI Strategic Services

      Providing our clients with legal, strategic, and practical advice to make transformational changes in their organizations.

    • eDiscovery

      Leveraging law and technology to deliver sound solutions.

    • Environmental, Social, and Governance (ESG)

      We help clients create positive return on investments in people, products, and the planet.

    • Global Services

      Delivering seamless service through partnerships across the globe.

    • Innovation

      Leveraging leading-edge technology to guide change and create seamless, collaborative experiences for clients and attorneys.

    • IPED

      Industry-leading conferences focused on affordable housing, tax credits, and more.

    • Legal Project Management

      Providing actionable information to support strategic decision-making.

    • Legally Green

      Teaming with clients to advance sustainable projects, mitigate the effects of climate change, and protect our planet.

    • Nixon Peabody Trust Company

      Offering a range of investment management and fiduciary services.

    • NP Capital Connector

      Bringing together companies and investors for tomorrow’s new deals.

    • NP Second Opinion

      Offering fresh insights on cases that are delayed, over budget, or off-target from the desired resolution.

    • NP Trial

      Courtroom-ready lawyers who can resolve disputes early on clients’ terms or prevail at trial before a judge or jury.

    • Social Impact

      Creating positive impact in our communities through increasing equity, access, and opportunity.

    • Women in Dealmaking

      We provide strategic counsel on complex corporate transactions and unite dynamic women in the dealmaking arena.

    1. Home
    2. Insights
    3. Alerts
    4. Whistleblower, DOJ spar over claim that DOJ’s investigations of cannabis industry mergers were politically motivated

      Alerts

    Alert / Antitrust & Cannabis Alert

    Whistleblower, DOJ spar over claim that DOJ’s investigations of cannabis industry mergers were politically motivated

    July 1, 2020

    LinkedInX (Twitter)EmailCopy URL

    By Gordon Lang

    On June 24, 2020, John Elias, a long-time prosecutor in the U.S. Department of Justice’s (DOJ’s) Antitrust Division, testified before the House Judiciary Committee that, at the direction of Attorney General William P. Barr, the DOJ investigated ten mergers in the cannabis industry despite the lack of any competitive issue and over the objections of the Antitrust Division’s career staff. The reason, Elias says, was that Mr. Barr does not like the product. According to Elias,

    • DOJ issued Second Requests—normally issued by DOJ when it believes a detailed investigation is necessary to determine if a merger may pose significant competitive harm and should be challenged—in nine of the mergers, and issued civil investigative demands in the tenth. Those Second Requests, he says, accounted for 29% of all of DOJ’s Second Requests over the relevant time, which is an unusually high percentage for an industry.
    • DOJ political leadership refused the staff’s attempts to narrow the Second Requests, leading to the production of almost six million documents over six of the investigations.
    • Another DOJ attorney also complained about DOJ’s cannabis merger investigations.
    • None of the investigations led to any DOJ cases.

    You can read Elias’s prepared remarks here: (Testimony of John W. Elias, U.S. House Committee on the Judiciary, June 24, 2020.

    For its part, the DOJ has strongly disputed Elias’s account. Spokeswoman Brianna Herlihy said the Department “strongly disagrees with (his) claim that the Antitrust Division acted inappropriately in any investigation.” The Antitrust Division contended that the cannabis industry presented “unique challenges” because the Division “lacked experience with the cannabis industry, that industry was rapidly expanding and consolidating, many cannabis companies are unsophisticated,” and it had only limited ability to collect information “because cannabis is illegal under federal law.” The two whistleblower complaints were reviewed by the DOJ’s Office of Professional Responsibility (OPR), and the night before Elias’s testimony, OPR issued a memo absolving the Antitrust Division of any wrongdoing.  

    After the House Judiciary Committee hearing, Senator Amy Klobuchar, Ranking Member of the Senate Judiciary Subcommittee on Antitrust, Competition Policy and Consumer Rights, and other Senate democrats [1] called for an immediate hearing on political interference in antitrust enforcement decisions at the DOJ. According to the letter, “Mr. Elias’s testimony before the House Judiciary Committee [wa]s damning. It eviscerate[d] the notion that investigations and enforcement decisions at today’s Antitrust Division are based on impartial assessments of law and fact.” The Senators have requested testimony from Elias and Antitrust Division head Makan Delrahim. Attorney General William P. Barr has agreed to appear before the House Judiciary Committee on July 28, 2020.


    1. Klobuchar was joined by Senators Patrick Leahy (D-VT), Sheldon Whitehouse (D-RI), Chris Coons (D-DE), Richard Blumenthal (D-CT), Cory Booker (D-NJ), and Kamala Harris (D-CA). [Back to reference]

    Practices

    Antitrust

    Industries

    Cannabis

    Insights And Happenings

    • Alert

      FTC scrutiny of CBD health-based representations

      Dec 23, 2020
    • Alert

      Cannabis legalized in New Jersey — is New York next?

      Nov 20, 2020
    The foregoing has been prepared for the general information of clients and friends of the firm. It is not meant to provide legal advice with respect to any specific matter and should not be acted upon without professional counsel. If you have any questions or require any further information regarding these or other related matters, please contact your regular Nixon Peabody LLP representative. This material may be considered advertising under certain rules of professional conduct.

    Subscribe to stay informed of the latest legal news, alerts, and business trends.Subscribe

    • People
    • Capabilities
    • Insights
    • About
    • Locations
    • Events
    • Careers
    • Alumni
    • Cookie Preferences
    • Privacy Policy
    • Terms of Use
    • Accessibility Statement
    • Statement of Client Rights
    • Purchase Order Terms & Conditions
    • Nixon Peabody International LLC
    • PAL
    © 2025 Nixon Peabody. All rights reserved